retatrutide glp3 GLP-3 RT – True Lab Peptides Retatrutide (GLP-3) — Peptide Triple
Description
Next-generation oral medications in development aim to match injectable efficacy, which would dramatically expand the patient population willing to consider treatment
Qiu, L., Nho, YH., Seilheimer, R.L
2018 Mar;20(3):610-619
[DOI] [PMC free article] [PubMed] [Google Scholar] 76.Zhao Y., Chen J., Andreatta M., Feng B., Xie Y.Q., Wenes M., Wang Y., Gao M., Hu X., Romero P., et al
Why is this hopeful
Summary: Joint pain is not a common class-wide side effect of GLP-1 receptor agonists, though musculoskeletal symptoms are listed in some product summaries with varying frequency
